Effect surgical menopause estrogen replacement cytokine release human blood mononuclear cells mononuclear cell secretory products changes bone turnover development postmenopausal osteoporosis effects oophorectomy subsequent estrogen replacement spontaneous secretion interleukin tumor necrosis factor alpha TNF-alpha phytohemagglutinin A-induced secretion granulocyte-macrophage colony-stimulating factor GM-CSF peripheral blood mononuclear cells healthy premenopausal women underwent oophorectomy increases GM-CSF activity early week surgery whereas elevations TNF-alpha hydroxyproline/creatinine calcium/creatinine ratios urinary indices bone resorption detectable weeks surgical procedure oophorectomized women estrogen therapy surgery subjects hydroxyproline/creatinine calcium/creatinine ratios weeks cytokines levels weeks oophorectomy study women estrogen replacement therapy weeks oophorectomy indices bone resorption decreases secretion cytokines levels weeks therapy women estrogen therapy osteocalcin marker bone formation preoperative levels weeks oophorectomy whereas estrogen-treated subjects unchanged entire study period female controls simple hysterectomy cytokine release biochemical indices bone turnover change surgery data changes estrogen status vivo secretion mononuclear cell immune factors vitro alterations local production bone-acting cytokines changes bone turnover menopause estrogen replacement 